23-May-2025Company News


Glenmark Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP 0.2%